Content
04/29/2025
Boston, MA USA
Basil Systems
completed $11.5 million Venture Round funding. Investors include
Golden Ventures (lead), Hearst Ventures, Argosy Capital.
About
Basil Systems delivers an AI-powered SaaS platform transforming how pharma and MedTech companies manage regulatory, clinical, and product lifecycle strategy. By structuring the world’s largest indexed database of regulatory, drug, device, and post-market data, Basil helps life sciences organizations accelerate development, reduce risk, and improve product performance. Trusted by industry leaders, Basil turns complex data into actionable insights that drive better decisions and better patient outcomes.
Startup
Sector:
AI
SaaS
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
